EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of 5-Phenylpyrazolopyrimidinone Analogs as Potent Antitrypanosomal Agents with In Vivo Efficacy

Yang Zheng iD, Magali van den Kerkhof, Tiffany van der Meer, Sheraz Gul, Maria Kuzikov, Bernhard Ellinger, Iwan J P de Esch iD, Marco Siderius, An Matheeussen, Louis Maes, Geert Jan Sterk, Guy Caljon und 1 weitere

Journal of Medicinal Chemistry · 2023

DOI: 10.1021/acs.jmedchem.3c00161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Yang Zheng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam Institute for Molecules, Medicines and Systems, Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boele…. Hauptthemen laut MEDLINE: Trypanocidal Agents, Trypanosomiasis, African, Trypanosoma brucei brucei. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FP7 Health, European Cooperation in Science and Technology, China Scholarship Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human African Trypanosomiasis (HAT), caused by Trypanosoma brucei, is one of the neglected tropical diseases with a continuing need for new medication. We here describe the discovery of 5-phenylpyrazolopyrimidinone analogs as a novel series of phenotypic antitrypanosomal agents. The most potent compound, 30 (NPD-2975), has an in vitro IC50 of 70 nM against T. b. brucei with no apparent toxicity against human MRC-5 lung fibroblasts. Showing good physicochemical properties, low toxicity potential, acceptable metabolic stability, and other pharmacokinetic features, 30 was further evaluated in an acute mouse model of T. b. brucei infection. After oral dosing at 50 mg/kg twice per day for five consecutive days, all infected mice were cured. Given its good drug-like properties and high in vivo antitrypanosomal potential, the 5-phenylpyrazolopyrimidinone analog 30 represents a promising lead for future drug development to treat HAT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trypanocidal AgentsTrypanosomiasis, AfricanTrypanosoma brucei bruceiMiceHumansAnimalsDrug DiscoveryDrug Development

Substanzen

Trypanocidal Agents

Autor:innen und Institutionen

  • Amsterdam Institute for Molecules, Medicines and Systems, Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands.
  • Laboratory of Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, 22525 Hamburg, Germany.
  • Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD, 22525 Hamburg, Germany.

ORCID-Profile: Yang Zheng, Iwan J P de Esch, Rob Leurs

Förderung

  • FP7 Health
  • European Cooperation in Science and Technology
  • China Scholarship Council

Zitieren

APA

Zheng, Y., van den Kerkhof, M., van der Meer, T., Gul, S., Kuzikov, M., Ellinger, B., de Esch, I. J. P., Siderius, M., Matheeussen, A., Maes, L., Sterk, G. J., Caljon, G., & Leurs, R. (2023). Discovery of 5-Phenylpyrazolopyrimidinone Analogs as Potent Antitrypanosomal Agents with In Vivo Efficacy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c00161

Vancouver

Zheng Y, van den Kerkhof M, van der Meer T, Gul S, Kuzikov M, Ellinger B, et al. Discovery of 5-Phenylpyrazolopyrimidinone Analogs as Potent Antitrypanosomal Agents with In Vivo Efficacy. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.3c00161

BibTeX
@article{Zheng2023,
  author = {Zheng, Yang and van den Kerkhof, Magali and van der Meer, Tiffany and Gul, Sheraz and Kuzikov, Maria and Ellinger, Bernhard and de Esch, Iwan J P and Siderius, Marco and Matheeussen, An and Maes, Louis and Sterk, Geert Jan and Caljon, Guy and Leurs, Rob},
  title = {Discovery of 5-Phenylpyrazolopyrimidinone Analogs as Potent Antitrypanosomal Agents with In Vivo Efficacy},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  doi = {10.1021/acs.jmedchem.3c00161}
}
Kostenlos starten →